We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Exova Grp | LSE:EXO | London | Ordinary Share | GB00BKY7HG11 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 238.50 | 239.00 | 239.75 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMEXO
RNS Number : 3761K
Exova Group PLC
21 September 2016
21(st) September 2016
Exova Group plc 2016 Capital Markets Day
Exova Group plc ("Exova" or "the Group"), a leading international provider of technically demanding testing and advisory services, will today hold its 2016 Capital Markets Day for institutional investors and analysts. The event will be held at the offices of Goldman Sachs, River Court, 120 Fleet Street, London EC4A 2BE.
Presentations will be given by members of Exova's senior management team, providing an update on strategy; details of Exova's new organisational structure; reconfirmation of the Group's investment proposition; and insight into the Fire and Building Products business.
There will be no discussion of the current trading performance at the event and the guidance for 2016 remains unchanged.
The presentation materials will be made available at 10am BST this morning to coincide with the start of the event. These can be found on Exova's website at www.exova.com.
Contacts
For further information please contact:
Peter Ogden, Powerscourt Group
Tel. +44 (0)20 7549 0997 / +44 (0)7793 858 211
Andy Jones, Powerscourt Group
Tel. +44 (0)20 7549 0797 / +44 (0)7766 024 408
exova@powerscourt-group.com
Exova
Exova is one of the world's leading laboratory-based testing groups, trusted by organisations to test and advise on the safety, quality and performance of their products and operations. Headquartered in Edinburgh, UK, Exova operates 138 laboratories and offices in 33 countries and employs more than 4,300 people throughout Europe, the Americas, the Middle East, Asia/Asia Pacific and Africa.
Exova's capabilities help to extend asset life, bring predictability to applications, and shorten the time to market for customers' products, processes and materials. With over 90 years' experience, Exova specialises in testing across a number of key sectors from health sciences to aerospace, transportation, oil and gas and construction.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKNEADLKEFF
(END) Dow Jones Newswires
September 21, 2016 02:00 ET (06:00 GMT)
1 Year Exova Chart |
1 Month Exova Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions